Skip to main content

Advertisement

Log in

Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

To investigate variations in expression of the monocyte antigen presentation molecule HLA-DR in cirrhosis.

Methods

HLA-DR expression was measured by flow cytometry in 100 patients within 48 h of admission and repeated a week later in 21 patients admitted to ICU. IL-10, TNF-α and IFN-γ secretion in response to lipopolysaccharide and recall antigens were measured by enzyme-linked immunosorbent spot (ELISPOT) assay in 12 patients (7 with clinical immunoparesis, 5 stable).

Results

HLA-DR level was 71% in stable patients, 53% with single organ dysfunction and 34% with multiple organ failure (p < 0.02). Within these groups, no significant differences in admission HLA-DR were seen between survivors and non-survivors. HLA-DR expression less than 40% predicted 90-day mortality with a specificity of 80% and sensitivity of 59% [area under the receiver operator curve (AUROC) 0.76]. HLA-DR less than 40% was an independent predictor of prognosis in multivariate analysis with a relative risk of 2.35 (p = 0.04), although sequential organ failure assessment score (SOFA) score displaced HLA-DR when included. In those admitted to intensive care failure to increase HLA-DR expression was predictive of death within 30 days (risk ratio 6.9, p = 0.007). Follow-up values predicted outcome with similar accuracy to acute physiology and chronic health evaluation II (APACHE II)/SOFA scores (AUROC 0.88). Response to endotoxin and recall antigen was characterised by an anti-inflammatory cytokine secretion profile, and was associated with impairment in recall antigen presentation capacity.

Conclusions

HLA-DR expression less than 40% and a failure of recovery predict poor outcome in decompensated cirrhosis, but overall prognostic power remains inferior to conventional markers. Ex vivo experiments demonstrate reduced Th1 response to antigenic stimulation and an exaggerated counter-inflammatory cytokine secretion profile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Tschaikowsky K, Hedwig-Geissing M, Schiele A, Bremer F, Schywalsky M, Schuttler J (2002) Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 30:1015–1023

    Article  CAS  PubMed  Google Scholar 

  2. Richter A, Nebe T, Kattermann R, Trede M (1996) Immune paralysis in acute pancreatitis–HLA-DR antigen expression on CD14+ DR+ monocytes. Langenbecks Arch Chir 381:38–41

    Article  CAS  PubMed  Google Scholar 

  3. Gibbons RA, Martinez OM, Lim RC, Horn JK, Garovoy MR (1989) Reduction in HLA-DR, HLA-DQ and HLA-DP expression by Leu-M3+ cells from the peripheral blood of patients with thermal injury. Clin Exp Immunol 75:371–375

    CAS  PubMed  Google Scholar 

  4. Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, Wendon J (2006) Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44:34–43

    Article  CAS  PubMed  Google Scholar 

  5. Wolk K, Docke WD, von Baehr V, Volk HD, Sabat R (2000) Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96:218–223

    CAS  PubMed  Google Scholar 

  6. Manjuck J, Saha DC, Astiz M, Eales LJ, Rackow EC (2000) Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med 135:153–160

    Article  CAS  PubMed  Google Scholar 

  7. Monneret G, Finck ME, Venet F, Debard AL, Bohe J, Bienvenu J, Lepape A (2004) The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95:193–198

    Article  CAS  PubMed  Google Scholar 

  8. Hynninen M, Pettila V, Takkunen O, Orko R, Jansson SE, Kuusela P, Renkonen R, Valtonen M (2003) Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock 20:1–4

    Article  CAS  PubMed  Google Scholar 

  9. Fumeaux T, Pugin J (2002) Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 166:1475–1482

    Article  PubMed  Google Scholar 

  10. Sfeir T, Saha DC, Astiz M, Rackow EC (2001) Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 29:129–133

    Article  CAS  PubMed  Google Scholar 

  11. Osuchowski MF, Welch K, Siddiqui J, Remick DG (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177:1967–1974

    CAS  PubMed  Google Scholar 

  12. Barsig J, Kusters S, Vogt K, Volk HD, Tiegs G, Wendel A (1995) Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha. Eur J Immunol 25:2888–2893

    Article  CAS  PubMed  Google Scholar 

  13. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD (1995) Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 181:1887–1892

    Article  CAS  PubMed  Google Scholar 

  14. Fumeaux T, Dufour J, Stern S, Pugin J (2004) Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med 30:2028–2037

    Article  PubMed  Google Scholar 

  15. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghoner A, Vidacek D, Siewert E, Bach J, Geier A, Purucker EA, Gressner AM, Matern S, Lammert F (2005) Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol 42:195–201

    Article  CAS  PubMed  Google Scholar 

  16. Berres ML, Schnyder B, Yagmur E, Inglis B, Stanzel S, Tischendorf JJ, Koch A, Winograd R, Trautwein C, Wasmuth HE (2009) Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis. Liver Int 29:536–543

    Article  CAS  PubMed  Google Scholar 

  17. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF (2009) Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 3:269–282

    Article  PubMed  Google Scholar 

  18. Lau GK, Suri D, Liang R, Rigopoulou EI, Thomas MG, Mullerova I, Nanji A, Yuen ST, Williams R, Naoumov NV (2002) Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 122:614–624

    Article  CAS  PubMed  Google Scholar 

  19. Cholongitas E, Betrosian A, Senzolo M, Shaw S, Patch D, Manousou P, O’Beirne J, Burroughs AK (2008) Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission. J Gastroenterol Hepatol 23:1223–1227

    Article  PubMed  Google Scholar 

  20. Klava A, Windsor AC, Farmery SM, Woodhouse LF, Reynolds JV, Ramsden CW, Boylston AW, Guillou PJ (1997) Interleukin-10. A role in the development of postoperative immunosuppression. Arch Surg 132:425–429

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip A. Berry.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 228 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berry, P.A., Antoniades, C.G., Carey, I. et al. Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive Care Med 37, 453–460 (2011). https://doi.org/10.1007/s00134-010-2099-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-010-2099-7

Keywords

Navigation